SIRPA and metabolic dysfunction-associated steatotic liver disease: We found that SIRPA, ATP2B1, RRBP1, SRRM2, SON, and RBM39 were significantly downregulated in NAFLD samples, while MAFB, CX3CR1, and DBI were significantly upgraded (Figure 5A).